Live from the NIH registry
Studies recruiting near Savannah right now
Top 25 of 167 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
HIV Infections
Phase 3
Interventional 590 participants sought
Chatham County Health Department — Savannah, Georgia (6.1 mi)
· Sponsor: Gilead Sciences
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Non-Small Cell Lung Cancer
Phase 3
Interventional 272 participants sought
Curtis and Elizabeth Anderson Cancer — Savannah, Georgia (6.1 mi)
· Sponsor: University of Texas Southwestern Medical Center
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Atrial Fibrillation (AF), Persistent Atrial Fibrillation
N/A
Interventional 400 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Medtronic Cardiac Ablation Solutions
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
Generalized Anxiety Disorder
Phase 2
Interventional 64 participants sought
CenExel iResearch, LLC — Savannah, Georgia (6.1 mi)
· Sponsor: Reunion Neuroscience Inc
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 4
Interventional 55 participants sought
Willett Children's Hospital at Memorial University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: American Thrombosis and Hemostasis Network
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Velocity Clinical Research - Savannah — Savannah, Georgia (6.1 mi)
· Sponsor: Amgen
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 160 participants sought
Atd002 52015 — Savannah, Georgia (6.1 mi)
· Sponsor: UCB Biopharma SRL
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Savannah, Georgia (6.1 mi)
· Sponsor: Massive Bio, Inc.
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: PedAL BCU, LLC
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Bluffton — Bluffton, South Carolina (23.7 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Charleston Neuroscience Institute - Bluffton (Site 124) — Bluffton, South Carolina (23.7 mi)
· Sponsor: EyeBiotech Ltd.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Gynecologic Oncology and Surgical Specialists at the Lewis Cancer & Research Pavilion — Savannah, Georgia (6.1 mi)
· Sponsor: American Society of Clinical Oncology
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Savannah, Georgia (6.1 mi)
· Sponsor: AstraZeneca
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Treatment-resistant Depression (TRD)
Phase 2
Interventional 178 participants sought
Site 7141 — Savannah, Georgia (6.1 mi)
· Sponsor: Alto Neuroscience
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: SWOG Cancer Research Network
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Phase 3
Interventional 284 participants sought
Aeroallergy Research Laboratory- Site Number : 8400036 — Savannah, Georgia (6.1 mi)
· Sponsor: Sanofi
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: University of Rochester
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Depressive Disorder, Major
Phase 3
Interventional 752 participants sought
iResearch Savannah — Savannah, Georgia (6.1 mi)
· Sponsor: Janssen Research & Development, LLC